sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Europe Anticoagulant Reversal Drug Market Scope And Analysis

  • Report Code : TIPRE00022194
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 146
Buy Now

Europe Anticoagulant Reversal Drug Market Scope and Analysis Report by 2027

Buy Now

Europe Anticoagulant Reversal Drug Market Report Europe Anticoagulant Reversal Drug Market Size and Share Europe Anticoagulant Reversal Drug Market Scope and Analysis

Europe Anticoagulant Reversal Drug Market Report Scope

Report Attribute Details
Market size in 2019 US$ 270.0 Million
Market Size by 2027 US$ 655.4 Million
Global CAGR (2019 - 2027) 12.4%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Product
  • Prothrombin Complex Concentrates
  • Vitamin K
  • Protamine
  • Tranexamic Acid
  • Idarucizumab
  • AndeXXa
By End User
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc
  • Octapharma AG
  • AMAG PHARMACEUTICALS INC
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals Inc Portola Pharmaceuticals
  • CSL Limited
  • Grifols S A